Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Bioprocess Automation Market Size, Value And Growth Trajectory Through 2030
The bioprocess automation market has experienced substantial growth in recent times. Projections indicate its value will rise from $6.4 billion in 2025 to reach $7.21 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 12.6%. This historical expansion is attributable to the increasing volume of biopharmaceutical manufacturing, the rising complexity in biologics production, the integration of programmable control systems, the need for consistent product quality, and the broadening of clinical manufacturing operations.
The bioprocess automation market is projected to experience substantial expansion over the coming years. By 2030, its value is anticipated to reach $11.52 billion, advancing with a compound annual growth rate (CAGR) of 12.4%. This growth during the projection period stems from escalating investments in continuous bioprocessing, a surging need for scalable automation platforms, the expansion of cell and gene therapy manufacturing, the incorporation of AI-driven process optimization, and the proliferation of intelligent biomanufacturing facilities. Key developments expected within this timeframe involve a greater uptake of automated bioprocess control platforms, increased incorporation of real-time process analytics, broader application of single-use bioprocessing automation, the broadening of closed-loop process control systems, and an intensified emphasis on data integrity and regulatory adherence.
Get A Free Sample Report With In-Depth Market Insights:
Bioprocess Automation Market Growth Backed By Core Demand Fundamentals
The expansion of personalized medicines is projected to propel the bioprocess automation market’s growth moving forward. Personalized medicine defines a medical methodology that tailors healthcare choices, practices, interventions, and treatments to align with the distinct attributes of each patient. Bioprocess automation aids personalized medicine by facilitating the accurate and scalable creation of patient-specific therapies. For instance, in February 2024, the Personalised Medicine Coalition, a US-based healthcare organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from six approvals in 2022. Thus, the increasing availability of personalized medicines is driving the advancement of the bioprocess automation market.
Bioprocess Automation Market Segment Landscape: Which Areas Lead Development?
The bioprocess automation market covered in this report is segmented –
1) By Component Of Process Control System: Sensors, Actuators, Controllers
2) By Scale Of Operation: Preclinical Operations, Clinical Operations, Commercial Operations
3) By Mode Of Operation: Batch, Fed-Batch, Perfusion
4) By Compatibility With Bioprocessing Systems: Single-Use Systems, Stainless Steel, Other Bioprocessing Systems
Subsegments:
1) By Sensors: Temperature Sensors, Pressure Sensors, Flow Sensors, Level Sensors, PH Sensors, Other Sensors
2) By Actuators: Electric Actuators, Pneumatic Actuators, Hydraulic Actuators, Other Actuators
3) By Controllers: Programmable Logic Controllers (PLC), Distributed Control Systems (DCS), Supervisory Control And Data Acquisition (SCADA), Other Controllers
Bioprocess Automation Market Growth Trends Reshaping The Competitive Landscape
Major companies in the bioprocess automation market are developing innovative solutions, such as bioreactors, to simplify bioprocessing operations. A bioreactor is an engineered system or device designed to provide an optimal and controlled environment for biological and chemical reactions. For instance, in April 2023, Cytiva, a US-based technology company that offers technologies and services to advance and accelerate the development and manufacturing of therapeutics, launched X-platform bioreactors to simplify single-use upstream bioprocessing operations. These bioreactors are easy to operate, flexible, and contribute to greater process efficiency. They were initially offered in 50 and 200 L capacities. They can enhance process efficiency through ergonomic improvements, increased production capability, and simplified supply chain operations. The X-platform bioreactors can be utilized for manufacturing cell and gene therapies, as well as viral vectors, in addition to monoclonal antibodies (mAbs).
Bioprocess Automation Market Industry Leaders And Competitive Landscape
Major companies operating in the bioprocess automation market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Parker-Hannifin Corporation, Rockwell Automation Inc., Agilent Technologies Inc., Lonza Group AG, Waters Corporation, Getinge AB, Eppendorf SE, Repligen Corporation, BIONET Engineering, Pierre Guerin Technologies, Bioengineering AG, Genedata AG, ILS Automation LLC, INFORS HT AG, Synthace Ltd., Automated Control Concepts Inc., BlueSens gas sensor GmbH, Securecell AG, Flownamics Analytical Instruments Inc., PendoTECH LLC, Sartorius Stedim Biotech S.A.
View The Full Bioprocess Automation Market Report:
Bioprocess Automation Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the bioprocess automation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess automation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
